Evidence map›Paper›PMID 31766714›Full record

ArticleNutrients2019

Dietary Omega-3 Fatty Acid Dampens Allergic Rhinitis via Eosinophilic Production of the Anti-Allergic Lipid Mediator 15-Hydroxyeicosapentaenoic Acid in Mice.

Kento Sawane, Takahiro Nagatake, Koji Hosomi, So-Ichiro Hirata, Jun Adachi, Yuichi Abe, Junko Isoyama, Hidehiko Suzuki, Ayu Matsunaga, Satoshi Fukumitsu and 4 more

Open access · goldAbstract read
In one paragraph

Article in Nutrients, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
5.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it, 75 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Review
  6. Review
  7. Eicosanoid profiles in an arthritis model: Effects of a soluble epoxide hydrolase inhibitor.Biochimica et biophysica acta. Molecular and cell biology of lipids · 2024
    Article
  8. Article
  9. Article
  10. The omega-3 postbioticFrontiers in cellular and infection microbiology · 2024
    Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 1 country.

Kento SawaneNippon Flour Mills Co., Ltd., Innovation Center, Kanagawa 243-0041, Japan.
Takahiro NagatakeLaboratory of Vaccine Materials, Center for Vaccine and Adjuvant Research and Laboratory of Gut Environmental System, National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), Osaka 567-0085, Japan.
Koji HosomiLaboratory of Vaccine Materials, Center for Vaccine and Adjuvant Research and Laboratory of Gut Environmental System, National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), Osaka 567-0085, Japan.
So-Ichiro HirataLaboratory of Vaccine Materials, Center for Vaccine and Adjuvant Research and Laboratory of Gut Environmental System, National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), Osaka 567-0085, Japan.
Jun AdachiLaboratory of Proteome Research, NIBIOHN, Osaka 567-0085, Japan.
Yuichi AbeDivision of Molecular Diagnosis, Aichi Cancer Center Research Institute, Nagoya 464-8681, Japan.
Junko IsoyamaLaboratory of Proteome Research, NIBIOHN, Osaka 567-0085, Japan.
Hidehiko SuzukiLaboratory of Vaccine Materials, Center for Vaccine and Adjuvant Research and Laboratory of Gut Environmental System, National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), Osaka 567-0085, Japan.
Ayu MatsunagaLaboratory of Vaccine Materials, Center for Vaccine and Adjuvant Research and Laboratory of Gut Environmental System, National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), Osaka 567-0085, Japan.
Satoshi FukumitsuNippon Flour Mills Co., Ltd., Innovation Center, Kanagawa 243-0041, Japan.
Kazuhiko AidaNippon Flour Mills Co., Ltd., Innovation Center, Kanagawa 243-0041, Japan.
Takeshi TomonagaLaboratory of Proteome Research, NIBIOHN, Osaka 567-0085, Japan.
Makoto AritaDivision of Physiological Chemistry and Metabolism, Graduate School of Pharmaceutical Sciences, Keio University, Tokyo 105-8512, Japan.ORCID 0000-0001-9902-0463
Jun KunisawaLaboratory of Vaccine Materials, Center for Vaccine and Adjuvant Research and Laboratory of Gut Environmental System, National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), Osaka 567-0085, Japan.
National Institute of Biomedical Innovation, Health and Nutrition · JPAichi Cancer Center · JPKeio University · JPNippon Flour Mills (Japan) · JPUniversity of Tsukuba · JP

Funding

the Canon Foundation -the Japan Agency for Medical Research and Development JP17ek0410032s0102, JP17ek0210078h0002, JP17ak0101068h0001, JP19ek0410062h0001the Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT)/Japanese Society for the Promotion of Science KAKENHI JP19K07617, JP18K17997, JP15H05790, JP17K09604, JP18H02150, JP18H02674the Ministry of Health and Welfare of Japan -the Ministry of Health, Labour, and Welfare of Japan JP19KA3001the Ono Medical Research Foundation -the Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries, and Food Industry -
6 · The paper itself

Abstract

The metabolism and generation of bioactive lipid mediators are key events in the exertion of the beneficial effects of dietary omega-3 fatty acids in the regulation of allergic inflammation. Here, we found that dietary linseed oil, which contains high amounts of alpha-linolenic acid (ALA) dampened allergic rhinitis through eosinophilic production of 15-hydroxyeicosapentaenoic acid (15-HEPE), a metabolite of eicosapentaenoic acid (EPA). Lipidomic analysis revealed that 15-HEPE was particularly accumulated in the nasal passage of linseed oil-fed mice after the development of allergic rhinitis with the increasing number of eosinophils. Indeed, the conversion of EPA to 15-HEPE was mediated by the 15-lipoxygenase activity of eosinophils. Intranasal injection of 15-HEPE dampened allergic symptoms by inhibiting mast cell degranulation, which was mediated by the action of peroxisome proliferator-activated receptor gamma. These findings identify 15-HEPE as a novel EPA-derived, and eosinophil-dependent anti-allergic metabolite, and provide a preventive and therapeutic strategy against allergic rhinitis.

Indexed as

Administration, IntranasalAnimalsAnti-Allergic AgentsDisease Models, AnimalEicosapentaenoic AcidEosinophilsFemaleInflammationLinseed OilLipid MetabolismMiceMice, Inbred C57BLPPAR gammaRhinitis, Allergic15-hydroxy-5,8,11,13,17-eicosapentaenoic acidAnti-Allergic AgentsEicosapentaenoic AcidLinseed OilPPAR gammaeosinophillipid metabolismnasal allergyomega-3 fatty acidsPPAR

Identifiers

PMID31766714
PMCPMC6950470
OpenAlexW2990165661

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.